Current drug development is inefficient
Unraveling the disease works better, faster
OUR APPROACH
We start with RNA...
|
Diseases aren't all the same and can change. RNA, unlike DNA, tells us exactly what's going on in the disease at that time. It's real time traffic data vs. a paper map. Just like you don't want to be distracted by maps of nearby cities while navigating, we focus on only what matters for a particular disease by comparing RNA data to our proprietary network and knowledge of interactions. |
Predict drugs that fix the problem...
|
We use the disease "map" and similar "maps" of what thousands of drugs do to predict which drugs will fix what's wrong. |
Quickly test drugs in patients...
|
For those patients with high unmet needs, we also identify approved drugs that can be prescribed by doctors today. We partner with clinicians and foundations to test drugs in the clinic as quickly as possible, after carefully showing the drug will be effective in disease models highly relevant to the specific disease. |
Identify drug targets and develop new drugs that improve patients' lives
|
In parallel to clinical tests of predicted drugs, we discover why they work: the drug target responsible and the mechanism through which it works. We also find out which patients are most likely to benefit and which biomarkers we can use to identify them. The best part is that we already know the target will work, so we then can develop new drugs for this target that can work even better. |